## NCNO: nCino, Inc. - XLK: Technology

### Executive Summary

VALUE thesis: PEG 0.77 indicates fundamental undervaluation. Consistent execution (3/4 quarters beat estimates).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($23.80)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 2
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. nCino stock price target lowered to $36 by UBS on FQ3 results**
- Source: Investing.com Nigeria | 20251209T150956 | Somewhat-Bullish | Relevance: 98%
- UBS has lowered its price target for nCino Inc. (NASDAQ:NCNO) to $36 from $39, while maintaining a Buy rating, following the company's strong fiscal third-quarter 2026 results that exceeded guidance. Despite the lowered target, nCino is considered undervalued with positive analyst consensus and growth initiatives making the "Rule of 40" achievable. The company also announced a $100 million share repurchase program and analysts have mixed responses with some raising targets and others lowering them based on different valuations.

**2. (NCNO) Movement as an Input in Quant Signal Sets**
- Source: Stock Traders Daily | 20251210T231600 | Somewhat-Bullish | Relevance: 98%
- This article analyzes Ncino Inc. (NASDAQ: NCNO) through AI-generated quantitative signals, identifying a stable neutral outlook in the short term despite long-term weakness. It details institutional trading strategies including position, momentum breakout, and risk hedging, alongside multi-timeframe signal analysis with specific support and resistance levels. The analysis highlights a 57.0:1 risk-reward setup targeting a 15.8% gain.

### Analyst Activity

**Target Signal:** BEARISH (Raises: 1, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-04 | Truist Securiti | $27 | $32 | -16% |
| 2025-12-04 | Needham | $38 | $38 | 0% |
| 2025-12-04 | Keefe, Bruyette | $36 | $34 | +4% |
| 2025-12-04 | Piper Sandler | $30 | $34 | -12% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-04 | Truist Securiti | main | Hold |
| 2025-12-04 | Needham | reit | Buy |
| 2025-12-04 | Keefe, Bruyette | main | Outperform |
| 2025-12-04 | Piper Sandler | main | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 6 ($0.82M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 47.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 5 |

**Top Holders:**
- Vanguard Group Inc: 10.4% (+1.7%)
- Kayne Anderson Rudni: 6.1% (-6.3%)
- HMI Capital Manageme: 5.9% (0.0%)
- Capital Internationa: 5.1% (-0.0%)
- Blackrock Inc.: 4.6% (+4.8%)

### Key Risks

1. Elevated short interest (12.3%): bears positioning against stock.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Momentum building: MRS_20 improving +10.8% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.77 indicates undervaluation relative to growth. Balance sheet: low leverage (D/E 0.49). Analyst sentiment negative (2 target cuts vs 1 raises). Institutional flow bullish (4 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $3.0B |
| Beta | 0.53 |
| 52W Range | $18.75 - $37.20 |
| Short Interest | 12.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.77 |
| Forward P/E | 25.2 |
| Current P/E | 28.6 |
| YoY Growth | 13.5% |
| EPS Direction | RISING |

### Technicals

MRS_20 strengthening from -8.2% to 2.5% (+10.8% in 5 days), confirming momentum buildup. Below STRENGTH zone by 1.5pp (needs >4.0% for momentum thesis). MRS_5 at 4.0% confirms short-term momentum alignment. AM_20 at 4.8% shows strong absolute momentum above own 20MA. Below SMA200 (0.96x), long-term trend not supportive. RSI neutral at 56.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 2.53% (CS: 62) | Neutral |
| RSI_14 | 56.0 | Neutral |
| MACD Histogram | 0.20 | Bullish |
| vs SMA20 | 1.048x | Above |
| vs SMA50 | 1.024x | Above |
| vs SMA200 | 0.963x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $25.92
- **Stop Loss:** $23.80 (8.2% risk)
- **Target:** $30.16 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 650
- **Position Value:** $16,848.00
- **Portfolio %:** 16.85%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-03-31 (Est: $0.21)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $0.21 | $0.31 | +49.9% |
| 2025Q3 | $0.14 | $0.22 | +58.1% |
| 2025Q2 | $0.16 | $0.16 | +1.8% |
| 2025Q1 | $0.18 | $0.12 | -34.9% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*